ImmunityBio, Inc. (IBRX) operating KPIs

IBRXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 8/30

$8.29−0.45 (-5.15%)

Close on Oct 30, 2026Market cap $8.79BP/E –Yield –

KPIs

Operating metrics that drive ImmunityBio's business

Coming soon

This tab will track the numbers specific to ImmunityBio's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.